Understanding muscle problems in myotonic dystrophy type 1
Mechanisms of Skeletal Muscle Pathogenesis in Myotonic Dystrophy Type 1
This study is looking into why people with myotonic dystrophy type 1 experience muscle weakness and wasting, focusing on how a specific genetic change affects muscle cells, and it hopes to find new ways to help treat this condition by working with patients to collect blood and muscle samples.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Baylor College of Medicine NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-10922861 on NIH RePORTER |
What this research studies
This research investigates the underlying mechanisms that lead to muscle weakness and wasting in individuals with myotonic dystrophy type 1 (DM1). The study focuses on how a specific genetic mutation affects RNA processing in muscle cells, leading to the misregulation of important proteins involved in muscle development. By examining the roles of certain RNA binding proteins, the research aims to uncover the reasons behind muscle degeneration in DM1, which could pave the way for new treatment strategies. Patients may be involved through the collection of blood samples and muscle tissue for analysis.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults diagnosed with myotonic dystrophy type 1 who are experiencing muscle weakness.
Not a fit: Patients with other forms of muscular dystrophy or those without a diagnosis of myotonic dystrophy type 1 may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that improve muscle function and quality of life for patients with myotonic dystrophy type 1.
How similar studies have performed: Previous research has shown promising results in understanding muscle pathogenesis in similar genetic disorders, indicating that this approach could yield valuable insights.
Where this research is happening
Houston, United States
- Baylor College of Medicine — Houston, United States (Active)
Researchers
- Principal investigator: Cooper, Thomas a — Baylor College of Medicine
- Study coordinator: Cooper, Thomas a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.